Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | HBB | P68871 | 1/20 | 0.55 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.55 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.55 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ELANE | P08246 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6036681 | 0.95 | TDP2 (0.52) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL12258322 | 0.92 | ALDH1A1 (0.54) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL1688847 | 0.90 | ALDH1A1 (0.55) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL2605006 | 0.88 | ALDH1A1 (0.60) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL30580334 | 0.88 | ALDH1A1 (0.66) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL224650 | 0.88 | ALDH1A1 (0.66) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL29392682 | 0.88 | ALDH1A1 (0.60) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL10885948 | 0.85 | ELANE (0.57) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL29634210 | 0.84 | CA1 (0.52) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR | |
| SCHEMBL4161497 | 0.84 | CA1 (0.52) | ALDH1A1MAPK1SMN1; SMN2L3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10550209-B2 | Catalysts for producing polymers and enhanced properties | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-02-04 | — | — | US | disclosed |
| US-10550209-B2 | Catalysts for producing polymers and enhanced properties | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-02-04 | — | — | US | disclosed |
| US-20180244816-A1 | Catalysts for Producing Polymers and Enhanced Properties | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-08-30 | — | — | US | disclosed |
| US-9988471-B2 | Catalysts for producing polymers with enhanced properties | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2018-06-05 | — | — | US | disclosed |
| US-9988471-B2 | Catalysts for producing polymers with enhanced properties | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2018-06-05 | — | — | US | disclosed |
| US-9988471-B2 | Catalysts for producing polymers with enhanced properties | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2018-06-05 | — | — | US | disclosed |
| US-20170174798-A1 | Catalysts for Producing Polymers with Enhanced Properties | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-06-22 | — | — | US | disclosed |
| US-20170174798-A1 | Catalysts for Producing Polymers with Enhanced Properties | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-06-22 | — | — | US | disclosed |
| WO-2017105635-A1 | CATALYSTS FOR PRODUCING POLYMERS WITH ENHANCED PROPERTIES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017105635-A1 | CATALYSTS FOR PRODUCING POLYMERS WITH ENHANCED PROPERTIES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-06-22 | — | — | WO | disclosed |
| EP-2061755-A1 | TRICYCLIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2009-05-27 | — | — | EP | disclosed |
| US-20090069408-A1 | TRICYCLIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2009-03-12 | — | — | US | disclosed |
| WO-2008109840-A1 | TRICYCLIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2008-09-12 | — | — | WO | disclosed |
| EP-0666267-B1 | Organometallic fluorenyl compounds, preparation, and use | PHILLIPS PETROLEUM CO (US) | 2001-04-18 | — | — | EP | disclosed |
| US-5571880-A | CATALYSTS FOR POLYMERIZATION OF OLEFINS ESPECIALLY TO OBTAIN SYNDIOTACTIC POLYMERS | PHILLIPS PETROLEUM COMPANY (US) | 1996-11-05 | — | — | US | disclosed |
| EP-0666267-A2 | Organometallic fluorenyl compounds, preparation, and use | PHILLIPS PETROLEUM COMPANY (US) | 1995-08-09 | — | — | EP | disclosed |
| EP-0531443-A4 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | — | 1993-04-21 | — | — | EP | disclosed |
| EP-0531443-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | NOVA PHARMACEUTICAL CORPORATION (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5079260-A | Side effect reduction; fluorene derivatives | NOVA PHARMACEUTICAL CORPORATION (US) | 1992-01-07 | — | — | US | disclosed |
| WO-1991018596-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | WEITZBERG MOSHE (US) | 1991-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069408-A1 | TRICYCLIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | TFRC, SLC40A1, FECH | ALDH1A1 1638/4885MAPK1 4346/4885SMN1; SMN2 1475/4885 |
| US-10550209-B2 | Catalysts for producing polymers and enhanced properties | PUF60, DBF4, PARN | ALDH1A1 2010/4885MAPK1 3980/4885SMN1; SMN2 2975/4885 |
| US-20180244816-A1 | Catalysts for Producing Polymers and Enhanced Properties | PUF60, DBF4, PARN | ALDH1A1 2010/4885MAPK1 3980/4885SMN1; SMN2 2975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.